课题基金 / 基金详情

Tec inhibitors- A new therapeutic for allergic diseases

Tec inhibitors- A new therapeutic for allergic diseases
Tec抑制剂——过敏性疾病的新疗法
批准号:
6608039
负责人:
Yuko Kawakami
金额:
$20.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2004-07-31

项目摘要

项目成果

Yuko Kawakami的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The incidence of allergic diseases such as atopic dermatitis (AD) has been dramatically increasing in the US and other industrialized countries for the past two decades. We and others have demonstrated that Tec family protein-tyrosine kinases have crucial roles in the activation of immune cells elicited by the engagement of antigen receptors or Fc receptors. As such, these kinases are supposed to play critical roles in the pathogenesis of AD and other allergic diseases that involve the activation of T and B lymphocytes, mast cells, and eosinophils. We recently identified a small-molecule compound, terreic acid (TA), as a selective inhibitor of Tec family kinases. In addition, we recently established highly efficient experimental conditions to rapidly induce skin lesions in AD-prone NC/Nga mice. Using this mouse model, we propose to explore whether TA or related compounds are therapeutically efficacious as a treatment of AD. Since we have a screening method for searching for Tec inhibitors whose usefulness has been proven, we will also expand our search for better compounds.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2332/allergolint.o-07-486
发表时间: 2007-12-01
期刊: Allergology international : official journal of the Japanese Society of Allergology
影响因子: --
作者: [Kawakami, Yuko, Yumoto, Kenji, Kawakami, Toshiaki]
通讯作者: Kawakami, Toshiaki
Tec inhibitors- A new therapeutic for allergic diseases
  • 批准号:
    6443542
  • 项目类别:
  • 资助金额:
    $23.36万
  • 财政年份:
    2002
  • 负责人:
    Yuko Kawakami
  • 依托单位:
海外基金